Thermo Fisher Scientific's launch of its Accelerator Drug Development follows expansions of sites in Cincinnati, Ohio, and Bend, Ore., earlier in 2024 to enable R&D, manufacturing, and testing.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

CPHI Milan Survey Predicts Faster CDMO Growth in 2025 While Finding No Industry Favor for BIOSECURE Act

By Feliza Mirasol

September 28th 2024

Results from the CPHI annual survey show that 49% of industry respondents are “highly positive” on the contract services sector seeing growth over the next 18 months.

SK pharmteco and Cryoport Collaborate on Cell and Gene Therapies

By Susan Haigney

September 26th 2024

The two companies are partnering to provide logistics and manufacturing services to biotechnology and pharma companies.

Delegation scheme or company structure. Figures and wooden arrows. | Image Credit: ©Vitalii Vodolazskyi - stock.adobe.com

Contracting Out Frees Sponsors Up

By Susan Haigney

August 4th 2024

Contract organizations offer sponsors specialized equipment, capacity, and expertise for testing, manufacturing, and packaging bio/pharmaceutical products.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - stock.adobe.com

Agilent Expands Biopharma Offerings with BIOVECTRA Acquisition

By Felicity Thomas

July 22nd 2024

The addition of BIOVECTRA’s biologics capabilities to accelerate drug development and manufacturing will allow Agilent to expand its end-to-end offerings for biopharma services.

...

4 5 6 7 8

About Us

Advertise

Editorial Information

Do Not Sell My Personal Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777